Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.51 [1.19-1.92],0.000763007243949633,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RSPO3,R-spondin-3,Inverse variance weighted,6,0.77 [0.63-0.93],0.00808782672659727,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.47 [1.07-2.02],0.0179856429426647,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.85 [0.74-0.98],0.0251936642541639,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.87 [0.77-0.98],0.0275959092238254,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,2.65 [1.06-6.6],0.0368278570010431,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.16 [1.01-1.33],0.0406261691949757,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,C7,Complement component C7,Inverse variance weighted,38,1.05 [1-1.1],0.0408163852849179,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.4 [0.17-0.97],0.0417638878725264,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.95 [0.9-1],0.0469372381482949,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.16 [1-1.33],0.0476123239622148,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LGALS4,Galectin-4,Inverse variance weighted,4,0.78 [0.61-1],0.0495763055300285,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PALM2,Paralemmin-2,Inverse variance weighted,8,1.15 [0.99-1.34],0.0617224953926039,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.68 [0.45-1.03],0.0689458829921115,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HSPB6,Heat shock protein beta-6,Wald ratio,1,2.31 [0.9-5.91],0.0801491999639084,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.85 [0.71-1.02],0.0873780472608925,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.93 [0.86-1.01],0.0915576443643991,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LGALS9,Galectin-9,Inverse variance weighted,26,1.07 [0.99-1.16],0.0953615061622539,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SPOCK1,Testican-1,Inverse variance weighted,6,0.83 [0.67-1.04],0.0995612783705907,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.09 [0.98-1.2],0.104739733488525,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,1.34 [0.94-1.91],0.105194090226748,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.93 [0.85-1.02],0.105283914808907,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,S100A14,Protein S100-A14,Wald ratio,1,0.55 [0.26-1.14],0.106896441464501,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.91 [0.82-1.02],0.1149090809966,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.82 [0.63-1.05],0.117677851578135,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,AREG,Amphiregulin,Inverse variance weighted,3,0.82 [0.65-1.05],0.118190910980765,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.62 [0.33-1.14],0.121517573779183,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.94 [0.86-1.02],0.124115963942948,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.61 [0.32-1.16],0.130537197374643,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,0.8 [0.6-1.07],0.131301339316719,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1.26 [0.93-1.7],0.131806005478753,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.74 [0.49-1.11],0.142223035110401,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NFASC,Neurofascin,Inverse variance weighted,15,0.94 [0.85-1.02],0.149293310089326,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.88 [0.74-1.05],0.149736558803924,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.93 [0.84-1.03],0.159724895724007,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.93 [0.83-1.03],0.159945999327691,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LMNB2,Lamin-B2,Wald ratio,1,0.52 [0.21-1.3],0.160063426765236,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.09 [0.96-1.24],0.169797592462001,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.93 [0.84-1.03],0.178921127521738,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.8 [0.76-4.27],0.183514684375956,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.95 [0.89-1.02],0.188374042508387,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.04 [0.98-1.1],0.188403989356416,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.9 [0.78-1.05],0.189153795016643,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LGALS3,Galectin-3,Inverse variance weighted,25,0.95 [0.88-1.03],0.189998473332525,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.93 [0.84-1.04],0.199234147480565,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.05 [0.97-1.13],0.203438891184946,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.04 [0.98-1.1],0.204244061230063,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,OGN,Mimecan,Inverse variance weighted,30,0.95 [0.88-1.03],0.205098324639595,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.07 [0.96-1.18],0.207730191014175,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.94 [0.85-1.04],0.211188245504309,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,EDN1,Endothelin-1,Inverse variance weighted,3,0.82 [0.6-1.13],0.227571333227756,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.95 [0.88-1.03],0.241432270880443,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.95 [0.88-1.03],0.247808925839375,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.03 [0.98-1.09],0.248881344440014,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.11 [0.93-1.32],0.253235349031749,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,BGLAP,Osteocalcin,Inverse variance weighted,2,1.36 [0.8-2.31],0.255761079791747,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.9 [0.74-1.08],0.257741251820074,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,MB,Myoglobin,Wald ratio,1,0.57 [0.21-1.55],0.273456055309105,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SEPTIN8,Septin-8,Inverse variance weighted,2,0.86 [0.66-1.12],0.273878505585318,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.94 [0.84-1.05],0.284154599630738,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.37 [0.76-2.49],0.296651788872241,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,F10,Coagulation factor X,Inverse variance weighted,9,1.04 [0.96-1.13],0.299028034966428,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.02 [0.98-1.07],0.306489271348667,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.03 [0.97-1.1],0.307746791388491,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.96 [0.88-1.04],0.310301240668525,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,AGRN,Agrin,Inverse variance weighted,17,1.07 [0.94-1.21],0.324629564911567,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.04 [0.96-1.13],0.32846583084141,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,UMOD,Uromodulin,Inverse variance weighted,29,1.02 [0.98-1.07],0.331892608335812,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SDC4,Syndecan-4,Inverse variance weighted,8,1.08 [0.92-1.28],0.34128296829071,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.92 [0.78-1.09],0.345080499346801,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.37 [0.7-2.66],0.352962007381915,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,KLK4,Kallikrein-4,Inverse variance weighted,17,1.04 [0.96-1.13],0.352981037558587,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.91 [0.74-1.11],0.356428372210458,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.06 [0.94-1.19],0.357312651196761,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.97 [0.9-1.04],0.362847455620884,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,0.92 [0.78-1.1],0.364911967305541,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.9 [0.72-1.13],0.369128915231704,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.77 [0.43-1.37],0.375831871765246,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.96 [0.88-1.05],0.379657337247584,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NTF3,Neurotrophin-3,Inverse variance weighted,8,1.08 [0.91-1.28],0.385950174843379,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,VWC2,Brorin,Inverse variance weighted,22,1.05 [0.94-1.16],0.388371536054411,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PKD1,Polycystin-1,Inverse variance weighted,12,0.95 [0.83-1.07],0.397740513499934,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.1 [0.88-1.37],0.3984748300183,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.83 [0.53-1.29],0.399583479369663,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CALCA,Calcitonin,Inverse variance weighted,5,1.13 [0.84-1.51],0.413115933683338,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.04 [0.95-1.13],0.420382760449456,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.86 [0.6-1.24],0.429941873446925,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.81 [0.47-1.4],0.440928100535054,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CST3,Cystatin-C,Inverse variance weighted,10,0.96 [0.85-1.07],0.445592972579704,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,OCLN,Occludin,Inverse variance weighted,2,1.25 [0.7-2.21],0.450699287908402,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.03 [0.95-1.13],0.451574002274254,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,0.72 [0.3-1.71],0.452005680498735,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.19 [0.76-1.86],0.456087878799546,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.05 [0.92-1.22],0.462624220527142,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.04 [0.94-1.14],0.465377655612411,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.12 [0.82-1.54],0.466168418321822,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.91 [0.7-1.18],0.47026424800068,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,0.92 [0.74-1.15],0.471656228852202,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.96 [0.86-1.08],0.474034584469663,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.92 [0.73-1.16],0.477243790516854,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ELN,Elastin,Inverse variance weighted,2,0.84 [0.51-1.38],0.485621096805569,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.92 [0.72-1.17],0.48911243766513,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.93 [0.77-1.14],0.493877482148867,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.97 [0.9-1.05],0.508128087623403,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.89 [0.62-1.27],0.513823345807977,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.91 [0.69-1.21],0.517217716792036,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,F7,Coagulation factor VII,Inverse variance weighted,21,0.97 [0.89-1.06],0.540481869439851,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.9 [0.64-1.26],0.544131383900953,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.02 [0.96-1.08],0.560293180066311,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PLA2G1B,Phospholipase A2,Wald ratio,1,0.83 [0.43-1.58],0.568524695199637,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.05 [0.89-1.23],0.581222103221699,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.94 [0.74-1.19],0.583763236634416,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.97 [0.85-1.1],0.599549778689502,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.97 [0.85-1.1],0.604149039384359,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,1.02 [0.95-1.09],0.6110495019541,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCG2,Secretogranin-2,Wald ratio,1,0.82 [0.37-1.8],0.613713369906962,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.18 [0.62-2.23],0.61759323904142,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.87 [0.5-1.51],0.620766938759968,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.98 [0.91-1.06],0.622942909546377,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.03 [0.92-1.14],0.624752090554907,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.97 [0.87-1.09],0.637546048902326,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.08 [0.79-1.47],0.644906279891087,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD302,CD302 antigen,Inverse variance weighted,9,0.97 [0.86-1.1],0.648684401339713,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.06 [0.82-1.37],0.660945136983655,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.02 [0.93-1.12],0.663119352510256,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SPON2,Spondin-2,Inverse variance weighted,4,0.96 [0.82-1.14],0.672112442543502,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LAYN,Layilin,Inverse variance weighted,20,1.02 [0.92-1.14],0.678901468736234,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.03 [0.88-1.22],0.67957047588655,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.85 [0.38-1.91],0.691670238825497,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,0.96 [0.79-1.17],0.696144101374521,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,REN,Renin,Inverse variance weighted,4,1.03 [0.9-1.17],0.70814521965039,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.05 [0.82-1.33],0.717349496288336,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PRSS2,Trypsin-2,Inverse variance weighted,3,0.96 [0.75-1.22],0.718042658678581,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RTBDN,Retbindin,Inverse variance weighted,3,1.04 [0.84-1.28],0.726290245212101,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.12 [0.6-2.07],0.726538108852202,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,MATN2,Matrilin-2,Inverse variance weighted,18,0.98 [0.87-1.1],0.727443063826577,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.96 [0.77-1.21],0.734628769147226,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.98 [0.87-1.1],0.740633815320935,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PALM,Paralemmin-1,Inverse variance weighted,6,1.03 [0.86-1.25],0.74149867763036,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.01 [0.94-1.09],0.762751615621722,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PENK,Proenkephalin-A,Inverse variance weighted,19,1.01 [0.92-1.12],0.76993545061795,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.04 [0.78-1.39],0.77517167461779,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.08 [0.62-1.89],0.775526933340808,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1.13 [0.45-2.87],0.790174357936555,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GUCA2A,Guanylin,Inverse variance weighted,9,1.03 [0.85-1.24],0.792790951440586,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PGF,Placenta growth factor,Inverse variance weighted,2,1.19 [0.31-4.5],0.80086598042539,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.99 [0.9-1.08],0.804253981623827,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.97 [0.69-1.34],0.835522639873405,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.01 [0.91-1.12],0.837221413522833,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.01 [0.9-1.14],0.84655137163412,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CALB2,Calretinin,Wald ratio,1,0.94 [0.51-1.73],0.851061301426831,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CCN5,CCN family member 5,Inverse variance weighted,8,1.04 [0.67-1.63],0.855660691136364,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SPON1,Spondin-1,Inverse variance weighted,21,1.01 [0.9-1.14],0.864923095593366,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CSTB,Cystatin-B,Inverse variance weighted,28,1.01 [0.93-1.09],0.866528183353013,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.97 [0.64-1.46],0.866927493089193,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.99 [0.89-1.1],0.870264542697134,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.98 [0.76-1.26],0.871778592717664,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.03 [0.73-1.44],0.874549713771275,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.96 [0.55-1.68],0.891996872068337,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CFD,Complement factor D,Inverse variance weighted,11,0.99 [0.88-1.12],0.904382815261269,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.01 [0.83-1.24],0.910071235846048,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.94 [0.31-2.81],0.910766663167532,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COLEC12,Collectin-12,Inverse variance weighted,11,0.99 [0.82-1.2],0.922232984963431,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.01 [0.82-1.24],0.939170075811857,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1 [0.85-1.17],0.961074949424793,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1 [0.89-1.13],0.970320961239861,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.01 [0.6-1.7],0.974522747638281,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,1 [0.74-1.35],0.986073438250738,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LGALS1,Galectin-1,Inverse variance weighted,6,1 [0.89-1.12],0.993385623241115,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1 [0.72-1.39],0.997364802152828,cis
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LMNB2,Lamin-B2,Inverse variance weighted,8,1.61 [1.23-2.11],0.000567668089057178,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.69 [0.53-0.89],0.00401918727255809,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LEP,Leptin,Inverse variance weighted,4,0.48 [0.28-0.82],0.00663331127780304,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,C7,Complement component C7,Inverse variance weighted,26,1.1 [1.02-1.19],0.0194301174743963,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.55 [0.33-0.92],0.0219612729295523,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SPON2,Spondin-2,Inverse variance weighted,3,0.57 [0.34-0.95],0.0294120016444129,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.42 [1.03-1.96],0.0308093811920201,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.47 [0.23-0.95],0.0342964278428574,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.16 [1-1.35],0.0517527681155044,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.71 [0.5-1.01],0.0545905275902569,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LGALS9,Galectin-9,Inverse variance weighted,36,1.08 [1-1.16],0.0583818744435303,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,MB,Myoglobin,Inverse variance weighted,9,0.74 [0.53-1.01],0.0607713755639198,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PALM2,Paralemmin-2,Inverse variance weighted,9,1.15 [0.99-1.34],0.0638140889999474,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.77 [0.58-1.02],0.0651123645581412,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.89 [0.78-1.01],0.0697571760140828,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.61 [0.34-1.08],0.0879376832988908,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.11 [0.99-1.24],0.0880423691830505,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.62 [0.93-2.83],0.0911539917526458,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.42 [0.16-1.16],0.0944683841825408,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,REN,Renin,Inverse variance weighted,8,0.68 [0.44-1.07],0.0946618694641364,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,F10,Coagulation factor X,Inverse variance weighted,11,0.87 [0.75-1.03],0.0982360246090482,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.2 [0.96-1.48],0.105249642311646,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.47 [0.91-2.39],0.116627853490736,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,UMOD,Uromodulin,Inverse variance weighted,34,0.9 [0.8-1.03],0.117244543626101,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.94 [0.87-1.02],0.122367852132487,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.64 [0.36-1.13],0.126194924434643,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PTH,Parathyroid hormone,Inverse variance weighted,11,1.16 [0.96-1.41],0.126201857712394,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.95 [0.89-1.02],0.140204476880904,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.58 [0.86-2.89],0.142431063677372,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.13 [0.95-1.35],0.157500206163061,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.05 [0.98-1.13],0.16394559960032,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SPON1,Spondin-1,Inverse variance weighted,4,1.31 [0.89-1.92],0.164214118554495,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COLEC12,Collectin-12,Inverse variance weighted,3,1.42 [0.84-2.4],0.184729720706791,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,XG,Glycoprotein Xg,Inverse variance weighted,2,0.66 [0.36-1.23],0.191229672750513,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PKD1,Polycystin-1,Inverse variance weighted,12,0.86 [0.67-1.09],0.19938163158885,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.15 [0.93-1.44],0.200497724613631,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.13 [0.93-1.36],0.217234986360291,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,AREG,Amphiregulin,Inverse variance weighted,5,1.23 [0.88-1.73],0.223455710549865,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.85 [0.65-1.11],0.225605465863806,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,0.58 [0.23-1.44],0.236672806546277,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,0.84 [0.64-1.12],0.242371438796236,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.8 [0.55-1.16],0.242798054788753,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,OGN,Mimecan,Inverse variance weighted,37,0.96 [0.89-1.03],0.250837948601244,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.41 [0.77-2.59],0.269231046492794,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.03 [0.98-1.07],0.275400034704615,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,OCLN,Occludin,Inverse variance weighted,2,1.62 [0.67-3.92],0.280105473187736,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.81 [0.54-1.21],0.294135060611124,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NTF3,Neurotrophin-3,Inverse variance weighted,11,1.1 [0.92-1.32],0.295193090434048,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.15 [0.88-1.51],0.306777736650366,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.57 [0.19-1.7],0.310975478647522,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,1.19 [0.84-1.69],0.31968299424803,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.89 [0.7-1.13],0.327557014335546,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.18 [0.85-1.63],0.329611602627923,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.72 [0.37-1.4],0.332452505680477,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CST3,Cystatin-C,Inverse variance weighted,3,1.27 [0.77-2.11],0.350016732617003,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.93 [0.81-1.08],0.350122895771188,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.04 [0.96-1.12],0.353277095341945,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.06 [0.93-1.2],0.382386464227801,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.85 [0.58-1.24],0.386214346513644,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.22 [0.78-1.92],0.390891322721522,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PGF,Placenta growth factor,Inverse variance weighted,5,1.15 [0.84-1.58],0.395273289311574,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PLA2G1B,Phospholipase A2,Inverse variance weighted,20,0.94 [0.81-1.09],0.395414693486421,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.1 [0.88-1.37],0.3984748300183,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.11 [0.87-1.41],0.41110726552261,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.13 [0.84-1.52],0.418302971853845,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.05 [0.93-1.2],0.420419608920511,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCG2,Secretogranin-2,Inverse variance weighted,2,1.27 [0.71-2.27],0.42237487555376,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.83 [0.52-1.32],0.425307373318455,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.2 [0.77-1.86],0.428863351661173,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LGALS3,Galectin-3,Inverse variance weighted,15,0.93 [0.78-1.12],0.438603685427206,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.15 [0.8-1.63],0.451229678639972,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LGALS4,Galectin-4,Inverse variance weighted,15,0.97 [0.88-1.06],0.463148116661807,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.1 [0.85-1.42],0.475366746937643,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.93 [0.76-1.13],0.475633764583753,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.95 [0.82-1.1],0.479896392142942,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ELN,Elastin,Inverse variance weighted,10,0.87 [0.59-1.28],0.486406782053397,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,0.92 [0.74-1.16],0.48929715573781,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.05 [0.91-1.21],0.491389405618357,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.91 [0.71-1.18],0.492186985118109,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.02 [0.96-1.09],0.492488059779726,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GUCA2A,Guanylin,Inverse variance weighted,7,1.09 [0.85-1.4],0.495867782134417,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,BGLAP,Osteocalcin,Inverse variance weighted,8,1.1 [0.84-1.45],0.498686955871779,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.88 [0.59-1.29],0.501894510915966,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.81 [0.43-1.52],0.504884620192157,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,KLK4,Kallikrein-4,Inverse variance weighted,5,1.21 [0.68-2.15],0.509358273130424,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.04 [0.92-1.19],0.519944807666608,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PRSS2,Trypsin-2,Inverse variance weighted,17,1.05 [0.9-1.23],0.520558732360436,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1.16 [0.74-1.82],0.524101688321681,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.09 [0.83-1.45],0.531268054362875,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CCN5,CCN family member 5,Inverse variance weighted,12,1.04 [0.91-1.19],0.535871293349741,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CALCA,Calcitonin,Inverse variance weighted,13,1.07 [0.86-1.35],0.53677066738137,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.87 [0.56-1.36],0.537297029274491,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RSPO3,R-spondin-3,Inverse variance weighted,5,0.9 [0.66-1.25],0.540765701360628,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.08 [0.84-1.4],0.554724600570627,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SEPTIN8,Septin-8,Inverse variance weighted,4,0.9 [0.64-1.27],0.557795380790403,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.03 [0.94-1.12],0.569006368219887,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SDC4,Syndecan-4,Inverse variance weighted,35,1.03 [0.92-1.16],0.570442462644083,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.05 [0.88-1.26],0.578101158761944,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.92 [0.69-1.23],0.583646611015724,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.12 [0.75-1.67],0.583987654218591,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.06 [0.87-1.29],0.586546379588244,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,S100A14,Protein S100-A14,Inverse variance weighted,14,1.06 [0.86-1.3],0.589409070598831,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.08 [0.82-1.42],0.59110498599632,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.68 [0.16-2.84],0.592197437427385,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PENK,Proenkephalin-A,Inverse variance weighted,15,1.04 [0.9-1.21],0.594843697174282,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.08 [0.81-1.44],0.605210885269579,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.06 [0.84-1.36],0.614241310128333,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.15 [0.67-1.95],0.616174674290135,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.96 [0.82-1.12],0.617591077799821,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.12 [0.72-1.73],0.620805925216802,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,0.97 [0.87-1.09],0.626135293691171,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,VWC2,Brorin,Inverse variance weighted,12,1.06 [0.83-1.35],0.627159164553411,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.08 [0.78-1.5],0.65367978297001,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.04 [0.87-1.24],0.654578234034738,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.93 [0.69-1.27],0.65711078238411,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,IL6,Interleukin-6,Inverse variance weighted,6,0.94 [0.7-1.26],0.661969227531319,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LAYN,Layilin,Inverse variance weighted,3,0.89 [0.53-1.5],0.667024406144382,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.1 [0.72-1.67],0.670508475804594,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.89 [0.52-1.53],0.680568632362149,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.15 [0.58-2.29],0.68902266679563,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.03 [0.89-1.2],0.690285353874269,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,0.98 [0.88-1.09],0.694059640226139,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.45 [0.22-9.45],0.700382123874683,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.04 [0.85-1.28],0.702978261377443,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD302,CD302 antigen,Inverse variance weighted,11,0.96 [0.77-1.19],0.709473153802699,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.19 [0.47-2.99],0.710716428206872,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.07 [0.75-1.5],0.71911662282149,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.04 [0.83-1.31],0.721004557621003,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.12 [0.6-2.07],0.726538108852202,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CD99,CD99 antigen,Inverse variance weighted,4,1.06 [0.78-1.43],0.729368627234946,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,AGRN,Agrin,Inverse variance weighted,14,0.96 [0.77-1.2],0.731293605337302,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.91 [0.53-1.57],0.734095598616765,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CFD,Complement factor D,Wald ratio,1,0.87 [0.4-1.92],0.734977992329811,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.87 [0.4-1.92],0.736135895239072,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.1 [0.62-1.95],0.740246576143856,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.04 [0.8-1.37],0.75467276187535,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.06 [0.71-1.6],0.76289774405747,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,12,1.05 [0.76-1.44],0.767612602256177,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RTBDN,Retbindin,Inverse variance weighted,2,0.93 [0.57-1.53],0.775787431490961,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,0.97 [0.76-1.23],0.778520470133777,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PALM,Paralemmin-1,Inverse variance weighted,4,0.95 [0.66-1.36],0.783457878897587,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CSTB,Cystatin-B,Inverse variance weighted,23,1.01 [0.94-1.09],0.793971021585404,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.96 [0.72-1.29],0.79737480119577,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.1 [0.53-2.28],0.806355821057754,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.91 [0.4-2.07],0.814802363410299,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.05 [0.7-1.57],0.816720923625877,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.93 [0.49-1.79],0.837638089602469,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,MATN2,Matrilin-2,Inverse variance weighted,28,0.99 [0.93-1.06],0.852509872351198,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.97 [0.73-1.3],0.859387807329028,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.97 [0.71-1.33],0.861571870282989,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.06 [0.54-2.09],0.863803568382078,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.02 [0.82-1.26],0.887327335775316,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NFASC,Neurofascin,Inverse variance weighted,6,1.03 [0.72-1.46],0.890309569463681,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,0.97 [0.59-1.58],0.891501425245203,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.96 [0.55-1.68],0.891996872068337,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.04 [0.62-1.72],0.892065194305617,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.98 [0.77-1.26],0.898438208647348,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.01 [0.92-1.1],0.904991055040796,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.02 [0.78-1.33],0.905971003439951,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.04 [0.51-2.15],0.906244914155519,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.95 [0.42-2.17],0.909618317748696,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.98 [0.72-1.34],0.909985163618467,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.01 [0.82-1.24],0.919734151698154,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.98 [0.68-1.42],0.922572281578526,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.01 [0.9-1.13],0.924745148412712,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.99 [0.79-1.24],0.927234726114857,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,F7,Coagulation factor VII,Inverse variance weighted,10,0.98 [0.66-1.46],0.932387606349031,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.98 [0.67-1.45],0.933199440611606,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SPOCK1,Testican-1,Inverse variance weighted,26,1 [0.88-1.15],0.945304140059062,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.99 [0.67-1.46],0.952721165641531,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.01 [0.75-1.36],0.958675750924073,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1 [0.83-1.21],0.960640428438188,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.98 [0.39-2.43],0.963846125009333,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,1 [0.83-1.22],0.966428378336242,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.99 [0.64-1.53],0.970530706267916,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.99 [0.69-1.42],0.97530822520684,trans
Chapter IX Diseases of the circulatory system,I9_CARDMYO,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.01 [0.58-1.75],0.982152659192787,trans
